Market Size of Hemostasis Valve Industry
| Study Period | 2019 - 2029 |
| Base Year For Estimation | 2023 |
| Forecast Data Period | 2024 - 2029 |
| CAGR | 5.30 % |
| Fastest Growing Market | Asia Pacific |
| Largest Market | North America |
Major Players
*Disclaimer: Major Players sorted in no particular order |
Need a report that reflects how COVID-19 has impacted this market and its growth?
Hemostasis Valve Market Analysis
The significant factor attributing this market's growth is the increasing number of interventional procedures and surgical procedures worldwide. Rising patient pool with different illnesses and rising demand for intensive hemostasis devices is also fueling the market growth.
Heart disease is the world's major cause of death and accounted for 17.9 million fatalities in 2016, according to the WHO published data. Worldwide, the growth of the geriatric population has led to increased cardiovascular disease prevalence. Since 2011, the medical devices industry has seen an annual growth rate of around 4.5 percent. Rising occurrences of cardiovascular illnesses and an increase in the aging population have a significant impact on the growth of the market for the Hemostasis valve.
Hemostasis Valve Industry Segmentation
As per the scope of the report, Hemostasis valves enable medical providers by giving them flexibility in catheters and delivery systems of the next generation. If a catheter is inserted into a body for angiography or other applications, the hemostasis valve is the device that avoids blood reflux.
| By Product Type | |
| Hemostasis Valve Y-Connectors | |
| Double Y-Connector Hemostasis Valves | |
| One-Handed Hemostasis Valves | |
| Others |
| By Application | |
| Angiography | |
| Angioplasty |
| By End User | |
| Hospitals | |
| Other End Users |
| Geography | ||||||||
| ||||||||
| ||||||||
| ||||||||
| ||||||||
|
Hemostasis Valve Market Size Summary
The hemostasis valve market is experiencing growth driven by the increasing number of interventional and surgical procedures globally. This surge is attributed to a rising patient pool with various illnesses and a heightened demand for intensive hemostasis devices. The prevalence of cardiovascular diseases, particularly among the aging population, is a significant factor influencing market expansion. The hospital segment holds a dominant share, supported by the growth of healthcare infrastructure in developing countries. Enhanced hospital facilities, including improved patient safety and supportive services, are expected to further boost demand. As healthcare reforms and new government policies are implemented, hospitals are likely to see a substantial increase in patient numbers, thereby driving the market for hemostasis valves.
North America is anticipated to lead the hemostasis valve market throughout the forecast period, largely due to the rising prevalence of chronic disorders and a growing geriatric population. The region's focus on addressing cardiovascular diseases, which remain a leading cause of death, is expected to increase the demand for hemostasis devices. The market is moderately competitive, with a few major players dominating and actively engaging in acquisitions and product launches to strengthen their global positions. Key companies in the market include Boston Scientific Corporation, Merit Medical Systems, Teleflex Incorporated, Terumo Corporation, and Freudenberg Medical, all of which are contributing to the market's dynamic landscape.
Hemostasis Valve Market Size - Table of Contents
-
1. MARKET DYNAMICS
-
1.1 Market Overview
-
1.2 Market Drivers
-
1.2.1 Increasing Number of Interventional Procedures
-
1.2.2 Rising Incidence of Chronic Diseases
-
-
1.3 Market Restraints
-
1.3.1 Difficulties related to its use and supervision of these devices
-
-
1.4 Porter's Five Force Analysis
-
1.4.1 Threat of New Entrants
-
1.4.2 Bargaining Power of Buyers/Consumers
-
1.4.3 Bargaining Power of Suppliers
-
1.4.4 Threat of Substitute Products
-
1.4.5 Intensity of Competitive Rivalry
-
-
-
2. MARKET SEGMENTATION
-
2.1 By Product Type
-
2.1.1 Hemostasis Valve Y-Connectors
-
2.1.2 Double Y-Connector Hemostasis Valves
-
2.1.3 One-Handed Hemostasis Valves
-
2.1.4 Others
-
-
2.2 By Application
-
2.2.1 Angiography
-
2.2.2 Angioplasty
-
-
2.3 By End User
-
2.3.1 Hospitals
-
2.3.2 Other End Users
-
-
2.4 Geography
-
2.4.1 North America
-
2.4.1.1 United States
-
2.4.1.2 Canada
-
2.4.1.3 Mexico
-
-
2.4.2 Europe
-
2.4.2.1 Germany
-
2.4.2.2 United Kingdom
-
2.4.2.3 France
-
2.4.2.4 Italy
-
2.4.2.5 Spain
-
2.4.2.6 Rest of Europe
-
-
2.4.3 Asia-Pacific
-
2.4.3.1 China
-
2.4.3.2 Japan
-
2.4.3.3 India
-
2.4.3.4 Australia
-
2.4.3.5 South Korea
-
2.4.3.6 Rest of Asia-Pacific
-
-
2.4.4 Middle-East and Africa
-
2.4.4.1 GCC
-
2.4.4.2 South Africa
-
2.4.4.3 Rest of Middle-East and Africa
-
-
2.4.5 South America
-
2.4.5.1 Brazil
-
2.4.5.2 Argentina
-
2.4.5.3 Rest of South America
-
-
-
Hemostasis Valve Market Size FAQs
What is the current Hemostasis Valve Market size?
The Hemostasis Valve Market is projected to register a CAGR of 5.30% during the forecast period (2024-2029)
Who are the key players in Hemostasis Valve Market?
Boston Scientific Corporation, Merit Medical Systems, Teleflex Incorporated, Terumo Corporation and Freudenberg Medical are the major companies operating in the Hemostasis Valve Market.
